Recruiting
Acute lymphocytic leukaemia recurrent
RecruitingStudy of DDCART-CD19 cells with cyclophosphamide and fludarabine for children and young adults (up to 39 years) with recurrent acute leukemia after stem cell transplant
Registered drugNo placebo
Study of DDCART-CD19 cells with cyclophosphamide and fludarabine for children and young adults (up to 39 years) with recurrent acute leukemia after stem cell transplant
Registered drugNo placebo
- Disease:Acute lymphocytic leukaemia recurrent
- Substances:CyclophosphamideDdcart‐Cd19+1
Countries:
Greece
Greece- Participants:0–17 years · 18–64 years
- Substances:Cyclophosphamide
